z-logo
open-access-imgOpen Access
Acquired ALK Resistance Mutations Identified from Liquid Biopsy in an ALK-Rearranged Squamous Cell Lung Cancer Patient Treated with Sequential ALK TKI Therapy: A Case Report
Author(s) -
Bin Yao,
Xue Han,
Linrong Pang,
Caihong Xu,
Sisi Liu,
Cheng Xia,
Jun Chen
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s315832
Subject(s) - medicine , lung cancer , liquid biopsy , alk inhibitor , biopsy , cancer research , anaplastic lymphoma kinase , crizotinib , squamous cell cancer , oncology , pathology , cancer , malignant pleural effusion

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here